Effects of cornstarch treatment in very young children with type I glycogen storage disease
- PMID: 2373114
- DOI: 10.1007/BF02034750
Effects of cornstarch treatment in very young children with type I glycogen storage disease
Abstract
Three children aged 1-2 years with glycogenosis type I were treated with 2 g/kg bodyweight oral cornstarch per meal (4-5 times a day) for a period up to 16 months. In comparison to the previous dietary regimen (day and nocturnal feedings every 3 h) the cornstarch diet stabilised serum glucose profiles and dramatically improved secondary hyperlipoproteinaemia. Mean total triglycerides decreased up to one half, consistent with a fall of very low density lipoprotein-triglycerides up to two thirds. Metabolic acidosis and hyperuricaemia did not occur and normal growth rates (0.7-1 cm/month) were achieved. We conclude that the cornstarch regimen even in the age group up to 2 years can be considered as an efficient alternative in the treatment of glycogenosis type I patients with less frequent feedings and without nocturnal infusion.
Similar articles
-
Glucose therapy for glycogenosis type 1 in infants: comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings.J Pediatr. 1990 Sep;117(3):384-91. doi: 10.1016/s0022-3476(05)81077-7. J Pediatr. 1990. PMID: 2202802
-
[Carbohydrates in the treatment of glycogenoses].Infusionstherapie. 1990 Apr;17(2):69-72. Infusionstherapie. 1990. PMID: 2113038 German.
-
Early introduction of uncooked cornstarch for the treatment of glycogen storage disease type I.Acta Paediatr Scand. 1990 Oct;79(10):978-9. doi: 10.1111/j.1651-2227.1990.tb11366.x. Acta Paediatr Scand. 1990. PMID: 2264476 Clinical Trial. No abstract available.
-
Dietary dilemmas in the management of glycogen storage disease type I.J Inherit Metab Dis. 2011 Jun;34(3):621-9. doi: 10.1007/s10545-011-9322-8. Epub 2011 Apr 14. J Inherit Metab Dis. 2011. PMID: 21491105 Review.
-
Life-style and serum lipids and lipoproteins.J Atheroscler Thromb. 2000;7(4):177-97. doi: 10.5551/jat1994.7.177. J Atheroscler Thromb. 2000. PMID: 11521681 Review.
Cited by
-
Nutritional deficiencies in a patient with glycogen storage disease type Ib.J Inherit Metab Dis. 1999 Oct;22(7):795-801. doi: 10.1023/a:1005549823146. J Inherit Metab Dis. 1999. PMID: 10518279
-
Dietary management in glycogen storage disease type III: what is the evidence?J Inherit Metab Dis. 2015 May;38(3):545-50. doi: 10.1007/s10545-014-9756-x. Epub 2014 Aug 28. J Inherit Metab Dis. 2015. PMID: 25164784 Review.
-
Lipids in hepatic glycogen storage diseases: pathophysiology, monitoring of dietary management and future directions.J Inherit Metab Dis. 2015 May;38(3):537-43. doi: 10.1007/s10545-015-9811-2. Epub 2015 Jan 30. J Inherit Metab Dis. 2015. PMID: 25633903 Free PMC article. Review.
-
Approach to the Neonate With Hypoglycemia.J Clin Endocrinol Metab. 2024 Aug 13;109(9):e1787-e1795. doi: 10.1210/clinem/dgae267. J Clin Endocrinol Metab. 2024. PMID: 38629854 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical